Cite
HARVARD Citation
Jin, C. et al. (2020). Pharmacodynamic study of prasugrel or clopidogrel in non-ST-elevation acute coronary syndrome with CYP2C19 genetic variants undergoing percutaneous coronary intervention (PRAISE-GENE trial). International journal of cardiology. pp. 11-17. [Online].